Navigation Links
McMaster University researchers discover drug destroys human cancer stem cells but not healthy ones
Date:5/24/2012

Hamilton, ON (May 24, 2012) -- A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.

"The unusual aspect of our finding is the way this human-ready drug actually kills cancer stem cells; by changing them into cells that are non-cancerous," said Mick Bhatia, the principal investigator for the study and scientific director of McMaster's Stem Cell and Cancer Research Institute in the Michael G. DeGroote School of Medicine.

Unlike chemotherapy and radiation, thioridazine appears to have no effect on normal stem cells.

The research, published today in the science journal CELL, holds the promise of a new strategy and discovery pipeline for the development of anticancer drugs in the treatment of various cancers. The research team has identified another dozen drugs that have good potential for the same response.

For 15 years, some researchers have believed stem cells are the source of many cancers. In 1997, Canadian researchers first identified cancer stem cells in certain types of leukemia. Cancer stem cells have since been identified in blood, breast, brain, lung, gastrointestinal, prostate and ovarian cancer.

To test more than a dozen different compounds, McMaster researchers pioneered a fully automated robotic system to identify several drugs, including thioridazine.

"Now we can test thousands of compounds, eventually defining a candidate drug that has little effect on normal stem cells but kills the cells that start the tumor," said Bhatia.

The next step is to test thioridazine in clinical trials, focusing on patients with acute myeloid leukemia whose disease has relapsed after chemotherapy. Bhatia wants to find out if the drug can put their cancer into remission, and by targeting the root of the cancer (cancer stem cells) prevent the cancer from comi
'/>"/>

Contact: Veronica McGuire
vmcguir@mcmaster.ca
90-552-591-402-2169
McMaster University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. McMaster researchers find potential for new uses of old drug
2. Women should still be concerned about hormone replacement therapy, say McMaster researchers
3. McMaster study finds more gut reaction to arthritis drugs
4. Milk better than water to rehydrate kids: McMaster study
5. Routine screening for autism not needed: McMaster researchers
6. McMaster scientists find protein’s bad guy role in prostate cancer
7. McMaster vaccine has pet owners feline groovy
8. Youth with IBD are less fit than their peers: McMaster study
9. McMaster study contradicts reports of problems with blood-thinner
10. McMaster researcher leads development of promising drug for inflammation
11. University studies and career expectations of medical students
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... a seasoned and trusted leader who consistently delivers trendy dresses ... it lead the wedding dress industry into the future. Today, ... the global market. , “The CEO of VogueQueen is uniquely ... continuing the goal of operational excellence and giving back to ...
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, has recently ... View website of AngelWeddingDress.com to find more details. ... online for a bridal party. AngelWeddingDress offers a variety ... Its maternity wedding dresses are specially designed for 2015. ...
(Date:1/22/2015)... York (PRWEB) January 22, 2015 Thousand ... Fresenius Medical Care recalled its GranuFlo and NaturaLyte dialysis ... litigation underway in U.S. District Court, District of Massachusetts, ... January 20th, the Court has remanded a case filed ...
(Date:1/22/2015)... NJ (PRWEB) January 22, 2015 Joan ... and keynote speaker at the upcoming 32nd Annual ... ACCME-accredited Physicians’ Education Resource®, LLC (PER®) , shares ... would have gone undetected if she had not followed ...
(Date:1/22/2015)... 22, 2015 IsoComforter, Inc. has introduced the ... patented IsoTube design to treat specific body parts and muscle ... progressive and easy to use patented cold therapy machine with ... related orthopedic and muscle injuries. IsoComforter has become the ...
Breaking Medicine News(10 mins):Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2
... Orderly Sale and Disposition of Hospital Assets,Patient Care to ... 24 Hospital Partners of America,("HPA" or "the Company") ... voluntary petitions of reorganization under Chapter 11,of the U.S. ... of,any of the hospitals in the HPA system, which ...
... LLC, founded,by Dr. Debbie Badawi, is an independent ... is focused on strengthening, empowering, and,rejuvenating families., ... 14-plus,years working with families, and my educational and ... unique needs," said Dr. Badawi.,"PeopleClick provides parents and ...
... be Bestowed , ... Nashville, TN (Vocus) September 24, ... academic year on Monday, September 29 at 9 a.m. with an ... Convocation. The first two non African-American graduates of Meharry will ...
... giant leaps for mankind through thousands of NASA innovations.,The ... industry businesses and advocacy groups, announced today the release ... Jr., who was the first African American to walk ... payload commander on two Space Shuttle flights. Dr. Harris ...
... Sept. 24 In response to,"Caffeinated Energy Drinks ... published,in the journal Drug and Alcohol Dependence, the ... "It,s unfortunate that the authors of this article ... a rhetorical attack when the facts of,their review ...
... and Elizabeth Medical Center, CHICAGO, Sept. 23 ... 2233 W. Division Street, is offering a,Coronary Calcium CT ... months,of October and November. A $500 value, this screening ... CT scanner, an,electrocardiogram and measurement of blood pressure, glucose ...
Cached Medicine News:Health News:Corporate Parent Hospital Partners of America Files Voluntary Chapter 11 Petition; Filings do not Include any Hospital Facilities 2Health News:PeopleClick, LLC Provides Cutting-Edge Servicing to Parents and Families 2Health News:First Two Non African-American Graduates of Meharry Medical College to Receive Awards at 2008 Fall Convocation 2Health News:First Two Non African-American Graduates of Meharry Medical College to Receive Awards at 2008 Fall Convocation 3Health News:First Two Non African-American Graduates of Meharry Medical College to Receive Awards at 2008 Fall Convocation 4Health News:Advancing Medical Technology from Space 2Health News:American Beverage Association Statement on Caffeinated Energy Drinks 2Health News:Heart CT Scan Helps Find Coronary Artery Disease 2
(Date:1/23/2015)... Jan. 23, 2015 For the pharmaceutical industry, marketplace success ... payers. Likewise, the importance of the managed markets function - ... to grow as payer formularies and provider networks play an ... At the same time, managed markets leaders must continually identify ...
(Date:1/23/2015)... 2015  The Partnership to Fight Chronic Disease (PFCD) released a public ... and a new study analyzing the impact of increased cost sharing ... coalition working to educate policy makers and the public on the ... focused on how the Iowa healthcare exchange ...
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, Inc. ... Biotechnology, Inc. for the compounding, packaging and distributing of its ... the United States . ... of compounding naltrexone tablets in various strengths for individual patients ...
Breaking Medicine Technology:As Payer Influence Rises, Pharmaceutical Companies work to Optimize the Managed Markets Function 2New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4
... recent study conducted by oculoplastic surgeon Charles Soparkar, ... a patent-pending formulation of zinc and phytase (trademarked ... oral administration for 4 days prior to a ... duration in 41 of 44 patients tested (93%). ...
... ABT ) announced today it has received approval from the U.S. ... e HBV assay for measuring viral load or the amount of ... first and only approved test capable of automating HBV viral load ... Abbott RealTi m e HBV assay, based on real-time PCR (polymerase ...
Cached Medicine Technology:Proprietary Zinc/Phytase Formulation Improved Botulinum Toxin A Results 2Abbott Receives FDA Approval for First Automated Molecular Test for Assessing Hepatitis B Treatment 2Abbott Receives FDA Approval for First Automated Molecular Test for Assessing Hepatitis B Treatment 3Abbott Receives FDA Approval for First Automated Molecular Test for Assessing Hepatitis B Treatment 4
Inquire...
... Designed for the scientist who wants ... the TE2000E2 is a high precision Z-focus ... This makes it possible to expand ... sources and image outputs. A five-way ...
... the most advanced motorized inverted microscope from ... optical design provides 9 access ports for ... four ports can have simultaneous access to ... Z-axis drive, 6-position nosepiece and light path ...
... exceptional performance for diverse applications ... unrivaled fluorescence imaging capabilities equal ... Developed for the highest fluorescence ... first-class optical illumination systems for ...
Medicine Products: